piracetam has been researched along with chitosan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishra, DN; Singh, SK | 1 |
| Abdallah, AA; Abomosallam, M; Elshatory, A; Gad El Hak, HN; Hendam, BM; Refaat, R | 1 |
2 other study(ies) available for piracetam and chitosan
| Article | Year |
|---|---|
Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice.
Topics: Acetylcholinesterase; Adhesiveness; Administration, Intranasal; Administration, Oral; Alzheimer Disease; Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Chitosan; Cholinesterase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Galantamine; Humans; Male; Maze Learning; Mice; Nanoparticles; Nasal Mucosa; Nootropic Agents; Piracetam; Scopolamine; Treatment Outcome | 2019 |
Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats.
Topics: Amyloid beta-Protein Precursor; Animals; Antioxidants; Caspase 3; Chitosan; Magnetic Phenomena; Nanoparticles; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Piracetam; Proto-Oncogene Proteins c-bcl-2; Rats | 2023 |